Table 3.
NP Spike Protein Haplotype Evolution in the Casirivimab-Imdevimab Treated Patients
| Number of Spike Protein Haplotypes | Patients (n = 36) | ||
|---|---|---|---|
| Day 0 | Day 3 | Day 7 | |
| 1 | 1 | ND/NC | 13 |
| 1 | 1 | 1 | 3 |
| 1 | ND/NC | 1 | 4 |
| 1 | 2 | ND | 6 |
| 1 | ND/NC | 2 | 2 |
| 1 | NC | 4 | 2 |
| 1 | 1 | 3 | 1 |
| 1 | 1 | 2 | 1 |
| 1 | 4 | ND | 1 |
| 2 | 1 | 1 | 1 |
| 2 | NC | 2 | 1 |
| 4 | 1 | ND | 1 |
Abbreviations: NC, not collected; ND, not detected; NP, nasopharyngeal.